All participants underwent comprehensive ophthalmic examinations, including assessments of best-corrected visual acuity, Goldmann applanation tonometry, refraction tests, slit-lamp biomicroscopy, gonioscopy, stereo disc photography, red-free fundus photography (EOS D60 digital camera; Canon, Utsunomiyashi, Japan), measurement of circumpapillary RNFL thickness using spectral-domain OCT (Spectralis; Heidelberg Engineering, Heidelberg, Germany), OCTA scanning of macular area (Heidelberg Engineering), and SITA standard 24-2 central 10° VF evaluation with Humphrey Field Analyzer II 750 (Carl Zeiss Meditec, Dublin, CA, USA). Eyes were divided into those with early and advanced POAG, based on a mean deviation (MD) of −6 dB on 24-2 VF tests.
28 The classification of the VF pattern was divided into paracentral scotoma, nasal step, and others according to the ocular hypertension treatment study classification
29 based on the 24-2 VF test results. Other ophthalmic examinations included measurements of corneal curvature (KR-1800; Topcon Optical Company, Tokyo, Japan), central corneal thickness (Orbscan II; Bausch & Lomb Surgical, Rochester, NY, USA), and axial length (IOLMaster version 5; Carl Zeiss Meditec). The baseline intraocular pressure (IOP) was defined as the mean of two measurements before starting IOP-lowering treatment.
POAG was defined as an open-angle on gonioscopy, signs of glaucomatous optic nerve damage (e.g., neuroretinal rim notching, thinning, or a localized RNFL defect), and a glaucomatous VF defect. A glaucomatous VF defect was defined as a defect conforming to one or more of the following criteria: (1) results outside normal limits on glaucoma hemi field tests, (2) at least three adjacent abnormal points with a P < 0.05 probability of being normal and at least one with a P < 0.01 probability by pattern deviation, or (3) a pattern standard deviation of P < 0.05, confirmed on two consecutive reliable tests. VF tests were considered unreliable if fixation losses were >33%, false-negative errors were >33% (except when the VF MD was <−12 dB), or false-positive errors were >15%. All tests were reviewed for the presence of artifacts, including inappropriate fixation, fatigue, inattention or learning effects, eyelid or rim artifacts, or any evidence that the results were affected by a condition other than glaucoma (e.g., homonymous hemianopsia).
Eyes were excluded if they had a best-corrected visual acuity worse than 20/40; a spherical equivalent <−9.0 D or >+3.0 D; a cylinder correction <−3.0 D or >3.0 D; a history of intraocular surgery, except for uneventful cataract surgery or trabeculectomy; or retinal or neurologic diseases. For the eyes that underwent cataract surgery, axial length >30 mm was considered an exclusion criterion instead of spherical equivalent criterion. For the eyes that underwent trabeculectomy, images that were obtained at least six months apart from the time of the surgery was used for analysis. If both eyes of a subject were eligible, one was randomly selected for inclusion in the study.